Gut Microbiome in Inflammatory Bowel Disease
Recruiting · NCT03589183 · Observational (researchers observe without assigning treatment) · Lead sponsor: Kyunghee University Medical Center
View the official record on ClinicalTrials.gov →What this trial is about
Inflammatory bowel disease (IBD) is a chronic inflammatory condition for gastrointestinal tract. There have been numerous studies to reveal dysbiosis of fecal/mucosal microbiome composition in IBD patients but actual trend of dysbiosis is strikingly different among patient's ethnicity. In this background, the investigators have composed a prospective cohort of Korean IBD patients in a large academic referral IBD center. Using an integrated multi-omics bioinformatic analysis, the investigators aim to explore gut microbial signatures along with distinct clinical/genetic features, and their potential interplay in patients with IBD.
Who can take part
Inclusion criteria
- Patients with established diagnosis of inflammatory bowel disease, including ulcerative colitis and Crohn disease
Exclusion criteria
- Person with history of using antibiotics or probiotics within previous 2 weeks.
Where it is running
2 locations listed.
- Kyung Hee University Hospital - Seoul, South Korea
- Kyung Hee University Hospital - Seoul, South Korea